http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
- 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
- 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
RISS 인기검색어
- 검색키워드
- 저자 : Naoka Murakami (검색결과 1 건)
- 무료
- 기관 내 무료
- 유료
-
Immune checkpoint inhibitors for solid organ transplant recipients: clinical updates
Shun Kawashima,Kole Joachim,Maen Abdelrahim,Ala Abudayyeh,Kenar D. Jhaveri,Naoka Murakami 대한이식학회 2022 Korean Journal of Transplantation Vol.36 No.2
Transplant care continues to advance with increasing clinical experience and improve- ments in immunosuppressive therapy. As the population ages and long-term survival improves, transplant patient care has become more complex due to comorbidities, frailty, and the increased prevalence of cancer posttransplantation. Immune check- point inhibitors (ICIs) have become a standard treatment option for many cancers in non-transplant patients, but the use of ICIs in transplant patients is challenging due to the possibility of disrupting immune tolerance. However, over the past few years, ICIs have gradually started to be used in transplant patients as well. In this study, we review the current use of ICIs after all solid organ transplantation procedures (kidney, liver, heart, and lung). Increasing data suggest that the type and number of immunosuppres- sants may affect the risk of rejection after immunotherapy. Immunotherapy for cancer in transplant patients may be a feasible option for selected patients; however, prospec- tive trials in specific organ transplant recipients are needed.
연관 검색어 추천
이 검색어로 많이 본 자료
활용도 높은 자료
